(Q34062648)

30 July 2017

1 reference

title

Secretoneurin: a functional neuropeptide in health and disease (English)

1 reference

30 July 2017

Wiedermann CJ

1

1 reference

30 July 2017

1 August 2000

1 reference

30 July 2017

10

1 reference

inferred from page(s)

published in

Peptides

1 reference

30 July 2017

21

1 reference

30 July 2017

8

1 reference

30 July 2017

1289-1298

1 reference

Sustained dopamine release induced by secretoneurin in the striatum of the rat: a microdialysis study

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin-like immunoreactivity in rat sympathetic, enteric and sensory ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Signaling in neuropeptide-induced migration of human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

The presence of secretoneurin in human synovium and synovial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Bovine posterior pituitary: presence of p65 (synaptotagmin), PC1, PC2 and secretoneurin in large dense core vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Staurosporine-dependent activation of human endothelial cell monolayers for neutrophil adherence by secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Immunohistochemistry of small intensely fluorescent (SIF) cells and of SIF cell-associated nerve fibers in the rat superior cervical ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Processing of secretogranin II by prohormone convertases: importance of PC1 in generation of secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Neurochemical compartments in the human forebrain: evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin-immunoreactivity in nerve terminals apposing identified preganglionic sympathetic neurons in the rat: colocalization with substance P and enkephalin.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Localization and axotomy-induced regulation of the peptide secretoneurin in the rat superior cervical ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin and chemoattractant receptor interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Proteolytic processing of chromogranin B and secretogranin II by prohormone convertases.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretogranin II: relative amounts and processing to secretoneurin in various rat tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Ontogenic development of secretogranin II and of its processing to secretoneurin in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Formation and sequence analysis of secretoneurin, a neuropeptide derived from secretogranin II, in mammalian, bird, reptile, amphibian and fish brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Distribution of chromogranins A and B and secretogranin II (secretoneurin) in rat pelvic neurons and vas deferens

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Proteolytic processing, axonal transport and differential distribution of chromogranins A and B, and secretogranin II (secretoneurin) in rat sciatic nerve and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

The processing of secretogranin II in the peripheral nervous system: release of secretoneurin from porcine sympathetic nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Concomitant changes of messenger ribonucleic acid levels of secretogranin II, VGF, vasopressin and oxytocin in the paraventricular nucleus of rats after adrenalectomy and during lactation.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain: an immunocytochemical and radioimmunological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparison with that of substance P and calcitonin gene-related peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

A determination of the solution conformation of secretoneurin, a neuropeptide originating from the processing of secretogranin II, by 1H-NMR and restrained molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Presence and distribution of a new neuropeptide, secretoneurin, in human retina

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin, a novel neuropeptide, in the human dental pulp.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Attraction of human monocytes by the neuropeptide secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Distribution and processing of secretoneurin in the developing rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Specific binding of a 125I-secretoneurin analogue to a human monocytic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin-induced in vitro chemotaxis of human monocytes is inhibited by pertussis toxin and an inhibitor of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin: a new peptide in the human enteric nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin: a market in rat hippocampal pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin: a new neuropeptide in the rodent pineal gland.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Co-localization of secretoneurin immunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Secretoneurin in bronchopulmonary carcinoids--immunohistochemical comparison with chromogranins A and B and secretogranin II

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900271-0

7 January 2021

10.1016/S0196-9781(00)00271-0

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11035217